Report - IQWiG-Berichte – Nr. 631 Ixekizumab (Psoriasis Arthritis) · Dossierbewertung A18-14 Version 1.0 Ixekizumab (Psoriasis Arthritis) 30.05.2018 Institut für Qualität und Wirtschaftlichkeit

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form